BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 11035013)

  • 1. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products.
    Ohgami N; Nagai R; Ikemoto M; Arai H; Kuniyasu A; Horiuchi S; Nakayama H
    J Biol Chem; 2001 Feb; 276(5):3195-202. PubMed ID: 11035013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD36, serves as a receptor for advanced glycation endproducts (AGE).
    Ohgami N; Nagai R; Ikemoto M; Arai H; Miyazaki A; Hakamata H; Horiuchi S; Nakayama H
    J Diabetes Complications; 2002; 16(1):56-9. PubMed ID: 11872368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products.
    Ohgami N; Nagai R; Ikemoto M; Arai H; Kuniyasu A; Horiuchi S; Nakayama H
    Ann N Y Acad Sci; 2001 Dec; 947():350-5. PubMed ID: 11795289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products.
    Ohgami N; Nagai R; Miyazaki A; Ikemoto M; Arai H; Horiuchi S; Nakayama H
    J Biol Chem; 2001 Apr; 276(16):13348-55. PubMed ID: 11278947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.
    Tamura Y; Adachi H; Osuga J; Ohashi K; Yahagi N; Sekiya M; Okazaki H; Tomita S; Iizuka Y; Shimano H; Nagai R; Kimura S; Tsujimoto M; Ishibashi S
    J Biol Chem; 2003 Apr; 278(15):12613-7. PubMed ID: 12473645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein.
    Marsche G; Zimmermann R; Horiuchi S; Tandon NN; Sattler W; Malle E
    J Biol Chem; 2003 Nov; 278(48):47562-70. PubMed ID: 12968020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism.
    Ohgami N; Miyazaki A; Sakai M; Kuniyasu A; Nakayama H; Horiuchi S
    J Atheroscler Thromb; 2003; 10(1):1-6. PubMed ID: 12621157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products and their recognition by macrophage and macrophage-derived cells.
    Horiuchi S; Higashi T; Ikeda K; Saishoji T; Jinnouchi Y; Sano H; Shibayama R; Sakamoto T; Araki N
    Diabetes; 1996 Jul; 45 Suppl 3():S73-6. PubMed ID: 8674898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products.
    Sano H; Higashi T; Matsumoto K; Melkko J; Jinnouchi Y; Ikeda K; Ebina Y; Makino H; Smedsrod B; Horiuchi S
    J Biol Chem; 1998 Apr; 273(15):8630-7. PubMed ID: 9535837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
    Acton SL; Scherer PE; Lodish HF; Krieger M
    J Biol Chem; 1994 Aug; 269(33):21003-9. PubMed ID: 7520436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36.
    Unno Y; Sakai M; Sakamoto Y; Kuniyasu A; Nakayama H; Nagai R; Horiuchi S
    Biochem Biophys Res Commun; 2004 Dec; 325(1):151-6. PubMed ID: 15522213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scavenger receptors that recognize advanced glycation end products.
    Miyazaki A; Nakayama H; Horiuchi S
    Trends Cardiovasc Med; 2002 Aug; 12(6):258-62. PubMed ID: 12242049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
    Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
    Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.
    Higashi T; Sano H; Saishoji T; Ikeda K; Jinnouchi Y; Kanzaki T; Morisaki N; Rauvala H; Shichiri M; Horiuchi S
    Diabetes; 1997 Mar; 46(3):463-72. PubMed ID: 9032104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II.
    Lougheed M; Lum CM; Ling W; Suzuki H; Kodama T; Steinbrecher U
    J Biol Chem; 1997 May; 272(20):12938-44. PubMed ID: 9148899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction.
    Araki N; Higashi T; Mori T; Shibayama R; Kawabe Y; Kodama T; Takahashi K; Shichiri M; Horiuchi S
    Eur J Biochem; 1995 Jun; 230(2):408-15. PubMed ID: 7607209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36.
    Kapinsky M; Torzewski M; Büchler C; Duong CQ; Rothe G; Schmitz G
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1004-10. PubMed ID: 11397711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that human Fc gamma receptor IIA (CD32) subtypes are not receptors for oxidized LDL.
    Morganelli PM; Groveman DS; Pfeiffer JR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3248-54. PubMed ID: 9409319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE).
    Jono T; Miyazaki A; Nagai R; Sawamura T; Kitamura T; Horiuchi S
    FEBS Lett; 2002 Jan; 511(1-3):170-4. PubMed ID: 11821070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.